1 Min Read
* Says Taiwan-based unit received drug clinical trials approval in Taiwan, for its injection named HLX06
Source text in Chinese:goo.gl/RhKq73
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.